In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent

a heat shock protein and fusion protein technology, applied in the field of in vivo ctl elicitation by heat shock protein fusion proteins, can solve the problems of inability to stimulate the production of cd8 t cells, generally fail to elicit effective cd8 t cell responses, etc., to achieve high-effective cd8+ ctl responses, prevent or reduce the length or severity of symptoms, and facilitate treatment

Inactive Publication Date: 2010-02-18
WHITEHEAD INST FOR BIOMEDICAL RES +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007]The invention has numerous advantages. For example, the compositions and methods described herein provide for highly effective CD8+ CTL responses. These responses are useful in treating (i.e., preventing or reducing the length or severity of symptoms associated with a disease process or preventing or attenuating the cellular events through which those symptoms are made manifest; treatment may be effective without completely eradicating all symptoms) diseases that are caused by or otherwise associated with intracellular pathogens. Diseases or conditions that are characterized by a deficiency (or complete lack of) CD4+ T cells are particularly amenable to treatment.

Problems solved by technology

These procedures generally fail, however, to elicit effective CD8 T cell responses.
Since injected protein antigens are generally unable to cross cellular lipid membranes, they fail to gain entry to the proper cytosolic “MHC class I processing pathway” and are thus unable to stimulate the production of CD8 T cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent
  • In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent
  • In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent

Examples

Experimental program
Comparison scheme
Effect test

example 1

In Vivo CTL Elicitation by hsp70 Fusion Proteins Maps to a Discrete Domain and is CD4+ T Cell-Independent

Materials and Methods

Expression Vectors:

[0051]All constructs used to produce OVA.hsp70 fusion proteins were made in the bacterial expression plasmid pKS11h (Suzue, K., et al., Proc. Natl. Acad. Sci. USA, 94:13146-13151 (1997)). Fusion constructs, consisting of OVA fused to the N-terminus of various segments of hsp70, were inserted downstream of the histidine tag sequence. A portion of ovalbumin (amino acid 230-359, hereafter referred to as OVA) was amplified from pOV230 (McReynolds, L. A., et al. Gene, 2:217-231 (1.977)) by PCR using upstream primer oQH025 and the downstream primer oQH027. Functional and structural domains of TBhsp70 based on crystal structures of ATP domain of bovine hsc70 (Flaherty, K. M., et al., Nature, 346:623-628 (1990)) and peptide-binding domain of E. coli DnaK (Zhu, X., et al., Science, 272:1606-1614 (1996)) were used. The lull-length TBhsp70 were separa...

example 2

Heat Shock Fusion Proteins Stimulate Dendritic Cells and Elicit

[0065]Production of Cytolytic T Lymphocytes Without Requiring Participation of CD4 T Cells

Methods and Materials

Mice, CTL Clones and Cell Lines

[0066]C57BL / 6 (H-2b), Cd-4-deficient (CD4 tm1Mak, H-2b), and C3H / HeJ mice (H-2k) were obtained from The Jackson Laboratories (Bar Harbor, Me.), maintained in barrier cages under specific pathogen free conditions, and immunized between 4- and 10-weeks of age. 2C TCR transgenic mice (H-2b) contain the rearranged transgenes encoding the ÿÿ TCR from a 2C CTL clone (Sha, W., et al., Nature, 335:271-274 (1988)), 2C TCR transgenic mice deficient for the recombination activating gene-1 (termed 2C / RAG) (Manning, T., et al., J. Immunol., 159:4665-4675 (1997)) were used as a source of naive T cells for in vitro assays (Cho, B., et al., Proc. Natl. Acad. Sci. USA, 96:2976-2981 (1999)), 2C CTL clone, L3.100, has been previously described (Sykulev, Y., et al., Immunity, 9:475-483 (1998)), EL4 ce...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a method of inducing a CD8+ CTL response to a molecule in an individual deficient in CD4+ T cells comprising administering to the individual art hsp or a portion of an ATP binding domain of an hsp joined to the molecule. In one embodiment, the present invention relates to a method of treating HIV in an individual deficient in CD4+ T cells comprising administering to the individual an hsp or a portion of an ATP binding domain of an hsp joined to the molecule. Also encompassed by the present invention is a method of inducing a CD4+ independent CTL response in an individual comprising administering to the individual a portion of an ATP binding domain of an hsp joined to the molecule. The present invention also relates to a method of inducing a CD8+ CTL response in an individual comprising administering to the individual a portion of an ATP binding domain of an hsp joined to the molecule. In addition, the present invention relates to a composition characterized by a portion of an ATP biding domain of an hsp joined to a molecule.

Description

RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 10 / 885,523, filed Jul. 1, 2004, which is a divisional of U.S. application Ser. No. 09 / 761,534, filed on Jan. 16, 2001. (now U.S. Pat. No. 6,875,435), which is a continuation of International Application No. PCT / US00 / 32831, which designated the United States and was filed on Dec. 1, 2000, which is published in English, and which claims the benefit of U.S. Provisional Application No, 60 / 176,143, filed on Jan. 14, 2000. The entire teachings of the above applications are incorporated herein by reference.GOVERNMENT SUPPORT[0002]The invention was supported, in part, by National Institutes of Health (NIH) training grant 5T32-AI-07463. NIH Cancer Center core grant CA-14051 and NIH research grants AI44476 and AI44478. The Government has certain rights in the invention.BACKGROUND OF THE INVENTION[0003]When injected into an individual with diverse adjuvants, protein antigens usually stimulate the producti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/385A61K38/16A61K38/14A61P37/04A61K45/00A61K38/00A61K39/00A61K39/02A61K39/04A61K39/12A61K39/21A61K47/48A61P31/04A61P31/18A61P35/00C07K14/35
CPCA61K39/00A61K47/48238C07K2319/00A61K2039/57C07K14/35A61K47/48276A61K47/62A61K47/6425A61P31/04A61P31/18A61P35/00A61P37/04
Inventor HUANG, QIANRICHMOND, JOAN F.L.CHO, BRYAN K.PALLISER, DEBORAHCHEN, JIANZHUEISER, HERMAN N.YOUNG, RICHARD A.
Owner WHITEHEAD INST FOR BIOMEDICAL RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap